Q2 EPS Estimates for Owens & Minor Cut by Leerink Partnrs

Owens & Minor, Inc. (NYSE:OMI) – Equities research analysts at Leerink Partnrs reduced their Q2 2025 earnings per share estimates for shares of Owens & Minor in a report issued on Thursday, February 20th. Leerink Partnrs analyst M. Cherny now expects that the company will earn $0.01 per share for the quarter, down from their previous estimate of $0.39. The consensus estimate for Owens & Minor’s current full-year earnings is $1.51 per share. Leerink Partnrs also issued estimates for Owens & Minor’s FY2025 earnings at $1.20 EPS.

A number of other equities analysts have also recently weighed in on OMI. Citigroup decreased their price objective on Owens & Minor from $21.00 to $18.50 and set a “buy” rating on the stock in a report on Tuesday, November 5th. Robert W. Baird lowered their price objective on shares of Owens & Minor from $14.00 to $10.00 and set a “neutral” rating for the company in a report on Tuesday. UBS Group reduced their target price on shares of Owens & Minor from $25.00 to $13.00 and set a “buy” rating on the stock in a report on Thursday, February 13th. Finally, Barclays lowered their price target on shares of Owens & Minor from $18.00 to $14.00 and set an “equal weight” rating for the company in a research note on Tuesday, November 5th. Two research analysts have rated the stock with a sell rating, five have assigned a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, Owens & Minor presently has a consensus rating of “Hold” and a consensus target price of $16.21.

Owens & Minor Stock Up 10.7 %

OMI opened at $7.08 on Monday. Owens & Minor has a one year low of $6.07 and a one year high of $28.35. The firm has a market capitalization of $545.55 million, a P/E ratio of -10.88, a price-to-earnings-growth ratio of 0.20 and a beta of 0.48. The company has a debt-to-equity ratio of 2.11, a current ratio of 1.09 and a quick ratio of 0.45. The company has a fifty day moving average price of $11.79 and a 200-day moving average price of $13.39.

Institutional Trading of Owens & Minor

Institutional investors and hedge funds have recently modified their holdings of the business. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its position in shares of Owens & Minor by 29.6% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 219,761 shares of the company’s stock valued at $2,872,000 after purchasing an additional 50,184 shares during the last quarter. Voloridge Investment Management LLC grew its position in Owens & Minor by 24.2% in the fourth quarter. Voloridge Investment Management LLC now owns 243,525 shares of the company’s stock worth $3,183,000 after acquiring an additional 47,459 shares in the last quarter. Squarepoint Ops LLC bought a new position in Owens & Minor during the fourth quarter valued at $381,000. State of Wyoming raised its position in Owens & Minor by 35.3% in the 4th quarter. State of Wyoming now owns 23,198 shares of the company’s stock worth $303,000 after purchasing an additional 6,050 shares during the period. Finally, ProShare Advisors LLC lifted its stake in shares of Owens & Minor by 44.5% during the 4th quarter. ProShare Advisors LLC now owns 22,702 shares of the company’s stock worth $297,000 after acquiring an additional 6,996 shares during the last quarter. Institutional investors own 98.04% of the company’s stock.

Owens & Minor Company Profile

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.